Literature DB >> 2686061

Immunocytochemical localization of estrogen and progesterone receptors in human thyroid.

S R Money1, W Muss, W L Thelmo, O Boeckl, W Pimpl, H Kaindl, P Sungler, J Kirwin, H Waclawicek, B M Jaffe.   

Abstract

The presence of steroid hormone receptors has previously been suggested in thyroid tissue by biochemical means. Our studies were designed to confirm these results and to localize the specific receptor-containing cell type using a novel immunocytochemical method. Monoclonal antibodies specific to estrogen receptors (ER) and progesterone receptors (PgR) were used to localize these steroid hormone receptors in the human thyroid gland. Frozen tissue sections from surgical specimens excised from 22 patients of both sexes with benign thyroid disease were studied. The sections were incubated with rat antiestrophilin and antiprogesterone receptor antibodies and were then exposed to rabbit anti-rat IgG and to rat peroxidase-antiperoxidase complex. The reaction product was visualized with diaminobenzidine tetrahydrochloride and hydrogen peroxide. Four specimens were positive for both ER and PgR, 16 were ER-positive and PgR-negative, and two were negative for both ER and PgR. Positive reactivity was limited to the follicular lining cell nuclei and varied from focal to diffuse. The immunohistochemical findings confirmed the presence of ER and PgR in the thyroid tissue and demonstrated for the first time that these receptors are present only in the nuclei of the lining cells of the thyroid follicle. The role of steroid hormone receptors in the thyroid in health and disease remains to be explained.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2686061

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Elevated thyroid autoantibodies and intracranial stenosis in stroke at an early age.

Authors:  Zhenghao Shi; Xuting Zhang; Zhicai Chen; David S Liebeskind; Min Lou
Journal:  Int J Stroke       Date:  2013-09-12       Impact factor: 5.266

2.  Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action.

Authors:  K S Banu; P Govindarajulu; M M Aruldhas
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  Interference of thyroperoxidase on immuno-cytochemical determination of steroid receptors in thyroid tissue.

Authors:  C Giani; D Campani; F De Negri; L Martini; R Fabbri; R Bonacci; E M Ciancia; A Gigliotti; P Fierabracci; A Pinchera
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

4.  Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue.

Authors:  R Bonacci; A Pinchera; P Fierabracci; A Gigliotti; L Grasso; C Giani
Journal:  J Endocrinol Invest       Date:  1996-03       Impact factor: 4.256

5.  Immunohistochemical Expression of Estrogen Receptor-α and Progesterone Receptor in Patients with Papillary Thyroid Cancer.

Authors:  Giacomo Sturniolo; Carles Zafon; Mariacarla Moleti; Josep Castellví; Francesco Vermiglio; Jordi Mesa
Journal:  Eur Thyroid J       Date:  2016-11-24

Review 6.  Thyroid autoimmunity and female gender.

Authors:  L Chiovato; P Lapi; E Fiore; M Tonacchera; A Pinchera
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

7.  Presence of immunoreactive corticotropin releasing hormone in thyroid lesions.

Authors:  C D Scopa; G Mastorakos; T C Friedman; M Melachrinou; M J Merino; G P Chrousos
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

8.  Role of estrogen in thyroid function and growth regulation.

Authors:  Ana Paula Santin; Tania Weber Furlanetto
Journal:  J Thyroid Res       Date:  2011-05-04

9.  Elevated Thyroid Autoantibodies Aggravate Stroke Severity in Euthyroidism with Acute Ischemic Stroke.

Authors:  Jingyi Li; Shoulong Hu; Fang Liu; Dapeng Wu; Wei Song; Miao Hui
Journal:  Dis Markers       Date:  2022-02-26       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.